China’s Sinopharm Covid-19 vaccine given WHO emergency approval
A WHO emergency listing allows the shot to be included in Covax, the global programme to provide vaccines mainly to poor countries
07 May 2021 - 18:16
Geneva — The World Health Organisation (WHO) announced on Friday it had approved a Covid-19 vaccine from China’s state-owned drugmaker, Sinopharm, for emergency use.
The vaccine, one of two main Chinese shots that collectively have already been given to hundreds of millions of people in China and abroad, becomes the first Covid-19 shot developed by a non-Western country to win the WHO’s backing...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.